Bosutris 400 Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Bosutinib (400mg)
Overview Bosutris 400 Tablet
Myeloidin 400mg tablets combat chronic myeloid leukemia, a type of blood cancer. This medication inhibits the proliferation and growth of cancerous cells, thus mitigating disease progression. Dosage and duration of Myeloidin 400mg treatment are determined solely by your physician. Consumption with or without food is acceptable. Adherence to a consistent daily schedule is crucial. Abrupt cessation is discouraged; continue as directed by your doctor. Frequently reported side effects include upper respiratory infections, nasal congestion, thrombocytopenia, leukopenia, anemia, cephalalgia, dyspnea, cough, elevated liver enzymes, diarrhea, emesis, nausea, and abdominal discomfort. Report any persistent or bothersome effects to your doctor; management strategies may be available. Seek immediate medical attention for severe headache, unilateral leg edema, dyspnea on exertion, or visual or auditory disturbances. Prior to initiating Myeloidin 400mg therapy, disclose all existing medical conditions and concurrent medications to your physician. This medication is contraindicated during pregnancy and lactation due to potential harm to the fetus.
Uses of Bosutris 400 Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Bosutris 400 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Bosutris 400 Tablet. Ingest the tablet whole; do not crush, chew, or break it. While you can take it with or without food, consistency in timing is recommended.
Common Side effects of Bosutris 400 Tablet:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Cough
- Low blood platelets
- Anemia (low number of red blood cells)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Respiratory tract infection
- Decreased white blood cell count (neutrophils)
- Breathlessness
- Increased liver enzymes
How to use Bosutris 400 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Bosutris 400 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, but consistency in timing is recommended.
How Bosutris 400 Tablet works:
Bosutris 400 mg tablets function as a tyrosine kinase inhibitor in cancer treatment. Its mechanism involves suppressing an aberrant protein responsible for cancerous proliferation and metastasis, thereby hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bosutris 400 Tablet may pose safety risks; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Taking Bosutris 400 Tablet during pregnancy is strongly discouraged due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Taking Bosutris 400 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Bosutris 400 Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Bosutris 400 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Bosutris 400 Tablets; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bosutris 400 Tablet :
Omit any missed Bosutris 400 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Bosutris 400 Tablet
| Label | Value |
|---|---|
| Chemical Type | Aminoquinoline derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |


